Results 141 to 150 of about 91,490 (255)

Commentary on "Protecting Against Unintended Risk From Student Quality Improvement Projects in Health Care". [PDF]

Adv Health Inf Sci Pract
Watzlaf VJM.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Improving outcomes by empowering nurses to lead change in an acute stroke unit. [PDF]

Nursing
Hutton EL, Manlangit DF, Curren B, Vettil M, Ali NA, Zayed E.   +5 more
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Dietitians as Food Systems Changemakers: The Path to Developing a Resilient, Equitable, Healthy and Connected Food System in the Illawarra Shoalhaven Region of Australia. [PDF]

J Hum Nutr Diet
Charlton K, Pickles S, Gebremariam AD, Stevens S, Stefoska-Needham A, Kent K.   +5 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Advancing global genomic equity: making a case for national genome projects in Africa. [PDF]

Nat Commun
Alimohamed MZ, El-Kamah G, Hamdi Y, Vicente-Crespo M, Ndiaye R, Ramsay M.   +5 more
europepmc   +1 more source

Digitalizing Finland:governance of government ICT projects

, 2019
Abstract Digitalization is a megatrend that also drives public sector reforms toward improved citizen service processes by adopting digital technologies. The digitalization of the public sector, also referred to as e-government transformation, is a strenuous institutional change process that starts with strategy and policy formation and is eventually ...
openaire   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

From pilot to region-wide impact: study protocol for an implementation study and randomised controlled trial of the LEX LOTSEN OWL Care and Case Management System. [PDF]

Trials
Arnold M, Gscheidle S, Lange S, Haring M, Stegmeier E, Klampfleitner H, Kurscheid C, Schluttig M, Borchers U, Stampa S, Schnecke JH, von Schell A, Pries R, Miethe J, Galle G, Brinkmeier M.   +15 more
europepmc   +1 more source